KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mks (MKSI) Cash & Equivalents (2016 - 2025)

Mks' Cash & Equivalents history spans 17 years, with the latest figure at $675.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 5.46% year-over-year to $675.0 million; the TTM value through Dec 2025 reached $675.0 million, down 5.46%, while the annual FY2025 figure was $675.0 million, 5.46% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $675.0 million at Mks, up from $655.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.1 billion in Q2 2022 and bottomed at $633.0 million in Q3 2021.
  • The 5-year median for Cash & Equivalents is $854.5 million (2023), against an average of $827.4 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 76.03% in 2021 before it fell 28.92% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $966.0 million in 2021, then decreased by 5.9% to $909.0 million in 2022, then fell by 3.74% to $875.0 million in 2023, then fell by 18.4% to $714.0 million in 2024, then fell by 5.46% to $675.0 million in 2025.
  • Per Business Quant, the three most recent readings for MKSI's Cash & Equivalents are $675.0 million (Q4 2025), $655.0 million (Q1 2025), and $714.0 million (Q4 2024).